Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-03

Clinical Trial Update: The Effect of Riboflavin in Crohn's Disease [NA]

View source ↗

Summary

Clinical trial investigating riboflavin in Crohn's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riboflavin (riboflavin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Crohn Disease | NA | Status: COMPLETED | Results posted: 2020-04-03